Wedbush Securities Inc. increased its stake in shares of CME Group Inc (NASDAQ:CME) by 13.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,102 shares of the financial services provider’s stock after purchasing an additional 587 shares during the quarter. Wedbush Securities Inc.’s holdings in CME Group were worth $745,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Valeo Financial Advisors LLC increased its position in CME Group by 71.1% during the 4th quarter. Valeo Financial Advisors LLC now owns 1,560 shares of the financial services provider’s stock valued at $228,000 after buying an additional 648 shares in the last quarter. Mariner Wealth Advisors LLC increased its position in CME Group by 52.7% during the 4th quarter. Mariner Wealth Advisors LLC now owns 4,014 shares of the financial services provider’s stock valued at $587,000 after buying an additional 1,385 shares in the last quarter. Wealthfront Inc. increased its position in CME Group by 7.9% during the 4th quarter. Wealthfront Inc. now owns 13,261 shares of the financial services provider’s stock valued at $1,937,000 after buying an additional 975 shares in the last quarter. Tower Research Capital LLC TRC increased its position in CME Group by 452.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,546 shares of the financial services provider’s stock valued at $810,000 after buying an additional 4,542 shares in the last quarter. Finally, Rhumbline Advisers increased its position in CME Group by 1.5% during the 4th quarter. Rhumbline Advisers now owns 671,701 shares of the financial services provider’s stock valued at $98,102,000 after buying an additional 10,178 shares in the last quarter. Hedge funds and other institutional investors own 82.63% of the company’s stock.
Several research analysts recently issued reports on CME shares. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective on the stock in a report on Tuesday, January 2nd. Goldman Sachs Group raised CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a report on Wednesday, February 7th. Citigroup reissued a “buy” rating and issued a $172.00 price objective (up from $155.00) on shares of CME Group in a report on Monday, January 29th. Finally, Berenberg Bank assumed coverage on CME Group in a report on Thursday, January 25th. They issued a “hold” rating and a $170.00 price objective on the stock. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. CME Group presently has an average rating of “Buy” and a consensus price target of $157.00.
In related news, COO Julie Holzrichter sold 12,920 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $144.08, for a total transaction of $1,861,513.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronald A. Pankau sold 200 shares of the firm’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $159.91, for a total value of $31,982.00. Following the sale, the director now directly owns 3,809 shares in the company, valued at $609,097.19. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 64,728 shares of company stock worth $9,755,257. 0.57% of the stock is owned by corporate insiders.
CME Group Inc (NASDAQ:CME) opened at $163.35 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.03 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $55,065.49, a PE ratio of 13.68, a PEG ratio of 2.10 and a beta of 0.64. CME Group Inc has a 1-year low of $114.82 and a 1-year high of $165.35.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping the consensus estimate of $1.10 by $0.02. The firm had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. CME Group had a return on equity of 7.68% and a net margin of 111.49%. CME Group’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period last year, the company earned $1.14 earnings per share. sell-side analysts anticipate that CME Group Inc will post 6.32 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Friday, March 9th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.71%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s dividend payout ratio (DPR) is 22.11%.
COPYRIGHT VIOLATION NOTICE: This report was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/02/21/wedbush-securities-inc-has-745000-position-in-cme-group-inc-cme.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.